Articles with public access mandates - Hatice Gulcin OzerLearn more
Available somewhere: 52
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
M Fabbri, A Paone, F Calore, R Galli, E Gaudio, R Santhanam, F Lovat, ...
Proceedings of the National Academy of Sciences 109 (31), E2110-E2116, 2012
Mandates: US National Institutes of Health
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib
JA Woyach, RR Furman, TM Liu, HG Ozer, M Zapatka, AS Ruppert, L Xue, ...
New England Journal of Medicine 370 (24), 2286-2294, 2014
Mandates: US National Institutes of Health, German Research Foundation
Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL
JA Woyach, AS Ruppert, NA Heerema, W Zhao, AM Booth, W Ding, ...
New England Journal of Medicine 379 (26), 2517-2528, 2018
Mandates: US National Institutes of Health
JNK3 perpetuates metabolic stress induced by Aβ peptides
SO Yoon, DJ Park, JC Ryu, HG Ozer, C Tep, YJ Shin, TH Lim, L Pastorino, ...
Neuron 75 (5), 824-837, 2012
Mandates: US National Institutes of Health
Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling
YY Yeh, HG Ozer, AM Lehman, K Maddocks, L Yu, AJ Johnson, JC Byrd
Blood, The Journal of the American Society of Hematology 125 (21), 3297-3305, 2015
Mandates: US National Institutes of Health
Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer
H Alder, C Taccioli, H Chen, Y Jiang, KJ Smalley, P Fadda, HG Ozer, ...
Carcinogenesis 33 (9), 1736-1744, 2012
Mandates: US National Institutes of Health
BRD4 profiling identifies critical chronic lymphocytic leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct BET inhibitor
HG Ozer, D El-Gamal, B Powell, ZA Hing, JS Blachly, B Harrington, ...
Cancer discovery 8 (4), 458-477, 2018
Mandates: US National Institutes of Health
Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia
AM Dorrance, P Neviani, GJ Ferenchak, X Huang, D Nicolet, KS Maharry, ...
Leukemia 29 (11), 2143-2153, 2015
Mandates: US National Institutes of Health
miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing
M Guerau-de-Arellano, H Alder, HG Ozer, A Lovett-Racke, MK Racke
Journal of neuroimmunology 248 (1-2), 32-39, 2012
Mandates: US National Institutes of Health
Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation
K Orlovsky, A Kalinkovich, T Rozovskaia, E Shezen, T Itkin, H Alder, ...
Proceedings of the National Academy of Sciences 108 (19), 7956-7961, 2011
Mandates: US National Institutes of Health
Chromatin modification by SUMO-1 stimulates the promoters of translation machinery genes
H Liu, J Zhang, GF Heine, M Arora, H Gulcin Ozer, R Onti-Srinivasan, ...
Nucleic acids research 40 (20), 10172-10186, 2012
Mandates: US National Institutes of Health
Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors
AS Yilmaz, HG Ozer, JL Gillespie, DC Allain, MN Bernhardt, KC Furlan, ...
Cancer 123 (7), 1184-1193, 2017
Mandates: US National Institutes of Health
Using gene co-expression network analysis to predict biomarkers for chronic lymphocytic leukemia
J Zhang, Y Xiang, L Ding, K Keen-Circle, TB Borlawsky, HG Ozer, R Jin, ...
BMC bioinformatics 11, 1-9, 2010
Mandates: US National Institutes of Health
Role of lysine methylation of NF-κB in differential gene regulation
T Lu, M Yang, DB Huang, H Wei, GH Ozer, G Ghosh, GR Stark
Proceedings of the National Academy of Sciences 110 (33), 13510-13515, 2013
Mandates: US National Institutes of Health
Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutations
F Lucas, K Larkin, CT Gregory, S Orwick, TJ Doong, A Lozanski, ...
Blood, The Journal of the American Society of Hematology 135 (24), 2192-2195, 2020
Mandates: US National Institutes of Health
Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia
JS Walker, ZA Hing, B Harrington, J Baumhardt, HG Ozer, A Lehman, ...
Journal of hematology & oncology 14, 1-21, 2021
Mandates: US Department of Energy, US National Institutes of Health, Cancer Prevention …
Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma
V Karkhanis, L Alinari, HG Ozer, J Chung, X Zhang, S Sif, RA Baiocchi
Journal of Biological Chemistry 295 (5), 1165-1180, 2020
Mandates: US National Institutes of Health
Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia
D Papaioannou, C Shen, D Nicolet, B McNeil, M Bill, M Karunasiri, ...
Proceedings of the National Academy of Sciences 114 (23), E4641-E4647, 2017
Mandates: US National Institutes of Health
Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia
CJ Walker, K Mrózek, HG Ozer, D Nicolet, J Kohlschmidt, D Papaioannou, ...
Blood advances 5 (5), 1474-1482, 2021
Mandates: US National Institutes of Health
Discovery and characterization of the feline miRNAome
A Laganà, WP Dirksen, W Supsavhad, AS Yilmaz, HG Ozer, JD Feller, ...
Scientific reports 7 (1), 9263, 2017
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program